The 132-year-old company, which specializes in pharmaceuticals, consumer health care, and medical devices, sells a wide array of health and beauty products including the Johnson’s Baby line, Neutrogena, Listerine, Band Aids, Tylenol, and Motrin. The company has been at the center of lawsuits concerning products that contain talc and their possible link to ovarian cancer and lung-related cancers, and has also been sued in connection with the opioid epidemic. But even amid legal conflicts and competition and pricing pressures in the industry, the company saw domestic sales increase 5.4% and international sales increase 7.4% in 2017. The company raised its sales outlook for 2018 due to the high performance of its pharmaceutical business, particularly cancer drugs.
Looking for leads, investment insights, or competitive intelligence?
News about Johnson & Johnson
Must-read business news, delivered every morning.
J&J will appeal the verdict, which it argues is "the product of a fundamentally unfair process."
The decision to sue is seen as an acknowledgment opioid makers won’t get serious about settling until the cases go to trial.
Mark Zuckerberg’s media tour is too little, too late.
The tech giant is stuck in a leadership crisis.